As of 2025-12-22, the Relative Valuation of HAVN Life Sciences Inc (HAVN.CN) is (1.32) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.03 CAD, the upside of HAVN Life Sciences Inc based on Relative Valuation is -4487.0%.
The range of the Relative Valuation is (1.25) - (1.29) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.3x - 3.4x | 2.8x |
| Forward P/E multiples | 1.5x - 2.4x | 2.0x |
| Fair Price | (1.25) - (1.29) | (1.32) |
| Upside | -4267.6% - -4413.9% | -4487.0% |
| Date | P/E |